Pharmacological Evaluation of SKL-18287, a New Long-Acting Glucagon-Like Peptide-1 Receptor Agonist with Enhanced Aggregation Propensity, in Rodent Models
Crossref DOI link: https://doi.org/10.1007/s10989-018-9777-7
Published Online: 2018-10-13
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Takeuchi, Mitsuaki
Okamoto, Masayuki
Watanabe, Nobuhide
Text and Data Mining valid from 2018-10-13
Article History
Accepted: 10 October 2018
First Online: 13 October 2018
Compliance with Ethical Standards
:
: The authors declare that they have no conflict of interest.